News

TG Therapeutics Raises Financial Outlook for 2024 and 2025

TG Therapeutics Raises Financial Outlook for 2024 and 2025

Positive News for TG Therapeutics

TG Therapeutics Inc (NASDAQ: TGTX) has seen a notable increase in its stock price recently as the company shared optimistic forecasts for its financial performance. With excitement surrounding their product BRIUMVI, TG Therapeutics is focused on growth and enhancing patient care.

What Is Happening With TG Therapeutics?

On a recent Tuesday, TG Therapeutics announced its projected revenue figures for the fourth quarter and full-year 2024. This guidance was eagerly awaited by investors and industry observers who are keen to understand the company's trajectory.

Financial Performance and Expectations

The company revealed that it anticipates a fourth-quarter net product revenue of approximately $103.6 million for BRIUMVI in the U.S. This figure is part of a larger expectation of around $310 million in total revenue for the full year 2024. Moreover, TG Therapeutics expects its year-end cash position to be approximately $310 million, reflecting a stable financial footing.

Development Milestones and Future Plans

During the J.P. Morgan Healthcare Conference, TG Therapeutics highlighted several critical milestones for 2025. They announced a forthcoming pivotal program aimed at introducing a subcutaneous version of BRIUMVI, which is poised for self-administration. This product is expected to transform the patient experience due to its convenient dosing schedule.

CEO's Vision for BRIUMVI

Michael Weiss, the chairman and CEO of TG Therapeutics, expressed confidence in the growing potential of BRIUMVI. He stated, "We believe BRIUMVI is well positioned to continue to grow and provide value to patients and physicians." This statement underscores the company’s commitment to addressing patient needs and market demands.

2025 Financial Targets Set High

Looking ahead, TG Therapeutics has set ambitious financial goals for 2025. The company is projecting total global revenue of approximately $540 million, with BRIUMVI alone expected to contribute about $525 million from U.S. net product revenue. Alongside this, operating expenses are targeted at around $300 million, painting a picture of projected profitability and continued investment in growth.

Enrollment and Trial Updates

In addition to revenue projections, TG Therapeutics plans a series of crucial development milestones. These include starting the pivotal program for subcutaneous BRIUMVI, increasing enrollment in trials assessing the drug's effectiveness for autoimmune diseases, and launching a Phase 1 trial for azer-cel in autoimmune conditions. Presentations of updated data will also be made at significant medical conferences, further reinforcing their research commitment.

TGTX Stock Market Reaction

As a reaction to the encouraging news, TG Therapeutics shares were reported up 7.8%, trading at about $29.85. This upward trend reflects investor confidence and enthusiasm about the company’s future prospects.

Frequently Asked Questions

What are the projected revenue figures for TG Therapeutics in 2024?

TG Therapeutics anticipates a fourth-quarter net product revenue of around $103.6 million for BRIUMVI, totaling approximately $310 million for the full year.

What is BRIUMVI?

BRIUMVI is a monoclonal antibody that targets CD20-expressing B-cells, aimed at treating conditions like Multiple Sclerosis.

What are TG Therapeutics' financial targets for 2025?

The company is projecting $540 million in total global revenue for 2025, with BRIUMVI U.S. net product revenue expected at approximately $525 million.

What milestones is TG Therapeutics planning for 2025?

Key milestones include launching a pivotal program for subcutaneous BRIUMVI and expanding enrollment in multiple ongoing trials.

How did the market react to TG Therapeutics’ announcements?

Upon hearing the positive news, TG Therapeutics shares rose by 7.8%, indicating strong market demand and confidence in their forecasts.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Composites One Unveils Game-Changing eCommerce Platform

Updated Category News Views 21

A New Era for Composites One? You know how companies often blast updates nobody asked for? Well, Composites One finally flipped the script. They've rolled out a completely revamped eCommerce platform across North America, and here's the kicker—it's actually built from the ground up on customer feedback. Yeah, they took the time to ask manufacturers what they needed for...

Continue Reading
Orthocell's Remplir™ Hits Record U.S. Sales in October

Updated Category News Views 176

Orthocell's October Surprise with Remplir™ Sales Well, isn't this a breath of fresh air? Orthocell Limited just reported a staggering rise in its U.S. Remplir™ sales for October 2026. We're talking 92 units shifting off the shelves, pulling in a tidy AU$279,000. That's an 84% leap compared to the average monthly sales of 50 units in Q1 FY27. It seems the company's...

Continue Reading
Amazon and CarbiCrete Innovate with Cement-Free Pavers

Updated Category News Views 88

Amazon Makes a Play for the Planet Look, I'm not one to sprinkle sugar on a cement-related chat, but I gotta say, this CarbiCrete deal has got my attention. Amazon, a titan known for its logistical empire, is diving headfirst into cement-free territory with CarbiCrete's products. In a world where cement production has been a stubborn carbon belcher, there's something big...

Continue Reading
D-Wave Quantum Faces Legal Heat: Key Investor Timelines

Updated Category News Views 76

Trouble Surfacing for D-Wave Quantum Investors It's another day, another dollar slipping out of an investor's pocket. Welcome to the circus. Today's main act? D-Wave Quantum, Inc., sporting a 9.51% drop in stock value. Now, those holding NASDAQ: QBTS shares during that class period between late February and August of 2026 might want to listen up. The lawyers over at...

Continue Reading
Investigation Looms Over ADT, Instacart, Ultralife Deals

Updated Category News Views 68

Corporate Deals Under the Microscope: What's at Stake? The headlines are shouting: ADT, Instacart, and Ultralife are all embroiled in merger activities that might not exactly be what shareholders signed up for. On the surface, you've got big names like DoorDash stepping up to snag some of these firms, but the question here is whether the deals are truly fair—or if...

Continue Reading
Milwaukee Cylinder Unveils Tech for Longevity in Tough Conditions

Updated Category News Views 115

Innovation Meets Contamination: ABC™ Technology Unleashed In the gritty halls of industrial manufacturing, equipment uptime can be the thin red line between profit and chaos. Milwaukee Cylinder just kicked it up a notch with their latest concoction: Active Barrier Chamber (ABC™) technology. This gizmo isn't just another shiny trinket; it's a genuine attempt to wrestle...

Continue Reading
Infinix Unveils Global Flagship Store in Bali

Updated Category News Views 140

Innovating Retail: Infinix Takes a Bold Step Imagine stomping the well-trodden grounds of Bali and striking the jackpot of tech experiences. That's right, Infinix is making waves with its first global Flagship Concept Store. Unveiled on October 31st, this venture is a serious flex from the tech giant, and it's absolutely in no mood to play small. The Flagship Store: A Hub...

Continue Reading
Abracon Unveils Engineer-Focused Website Features

Updated Category News Views 59

Pushing the Needle in Digital Engagement Some days, the market talk brews hotter than a Texas barbecue, and today it’s Abracon serving up something new. They're tossing engineers a fresh digital bone with revamped website accounts. No bells or whistles, just a clean shot at making techies' lives easier as they tinker and design. It's a world where getting your hands on...

Continue Reading
Fresenius, WuXi Biologics Blaze New Biosimilars Trail

Updated Category News Views 148

Fresenius Bets Big on Biopharma with WuXi Partnership A deal inked by Fresenius and WuXi Biologics is stirring up the biosimilars pot, aiming to widen Fresenius' grip on the market tenfold. We're not talking small potatoes here; we're talking up to 66 biosimilar molecules against a hefty backdrop of more than €370 billion in originator sales. It's as if they've said,...

Continue Reading
Tampa Welcomes Global Art Fair October 2026

Updated Category News Views 73

Tampa Steps into the Global Art Scene Get this, Tampa is gearing up for its slice of the global art pie. Come October 2026, the Tampa Convention Center will transform into a bustling hub of creativity and culture. With over 300 artists slated to pour in from every corner of the globe, this isn't just any old art fair—it's Art Fair Tampa, and it's promising to be a...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Impact of Job Reports on Market Volatility

Updated Category News Views 182

Understanding Market Dynamics Before Job Reports Recently, we witnessed a significant decline in rates, driven by an ISM services report that fell short of expectations. This has prompted discussions among market analysts about potential implications for various sectors and economic indicators. As a result, the 10-year Treasury bond yield experienced a dip to the 4.4%...

Continue Reading
Revenue Management Labs Expands PE Pricing Focus

Updated Category News Views 8

Digging Deeper into Private Equity’s Untapped Asset: Pricing Roll up those sleeves because Revenue Management Labs just rolled into New York, ready to stir the pot for private equity with a fresh take on pricing strategies. This ain’t your grandma’s pricing strategy; we’re talking AI-driven precision that sings across the mid-market and large-cap arenas. Based on...

Continue Reading
Bharat Electronics' Future Looks Bright Despite Recent Fluctuations

Updated Category News Views 365

Bharat Electronics' Investment Potential Assessment In recent evaluations by CLSA, Bharat Electronics Ltd (BHE:IN) has been recognized for its strong investment potential, despite a slight correction in stock value. The firm continues to uphold an Outperform rating for the company, reflecting confidence in its future prospects. With a price target set at INR294.00, CLSA's...

Continue Reading
Sharon AI Collaborates with Industry Leaders for Advanced Video Solutions

Updated Category News Views 486

Sharon AI Teams Up with Top Tech Companies Sharon AI, Inc., a vibrant force in high-performance computing and artificial intelligence, has recently taken a significant step forward by teaming up with several leading companies in the tech sector. This collaboration includes Next DC, Layercake, Grass Valley, and AI-MEDIA, with the aim of transforming cloud-based media...

Continue Reading
Market Trends and Future of Machine Tools Industry

Updated Category News Views 327

Overview of the Machine Tools Market Growth The machine tools market is on an impressive trajectory, with projections indicating it will soar from an estimated USD 106.55 billion in 2023 to USD 189.44 billion by 2032. This remarkable growth is expected to manifest at a compound annual growth rate (CAGR) of 6.65% from 2024 to 2032. The key factors contributing to this boom...

Continue Reading